WASHINGTON--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported second-quarter results, which include the May 24 acquisition of Evoqua Water Technologies Corp. (Evoqua). The Company reported total revenue of $1.7 billion, with reported growth of 26 percent and organic growth of 15 percent, surpassing prior guidance, on strong commercial and operational execution. Orders were up 10 percent on a reported basis and down 2 percent organically, while backlog grew to $5.3 billion, up 7 percent organically and including $1.3 billion from Evoqua, with resilient underlying demand. Second-quarter earnings, excluding the acquisition, exceeded Xylem’s previous stand-alone guidance.

“This past quarter, we took another transformative step as a leading water solutions company to help our communities and customers solve the greatest water challenges facing our society and economies: water scarcity, resilience of our infrastructure to climate change, and the need to address these challenges affordably with the power of technology and innovation,” said Patrick Decker, Xylem president and CEO. “These challenges are intensifying every day and our powerful portfolio is now even more strongly positioned to deliver solutions at scale.”

“We are already seeing the momentum created by integrating two strong companies. On the strength of the market’s continuing underlying demand and our team’s disciplined execution, we are further raising our full-year guidance on revenues, margins and earnings per share.”

Net income was $92 million, or $0.45 per share. Net income margin decreased 290 basis points to 5.3 percent. These results are driven by higher acquisition and integration costs related to the Evoqua transaction, higher purchase accounting intangible amortization, and higher restructuring and realignment costs, more than offsetting strong operational performance. Coinciding with the Evoqua acquisition, Xylem has updated its adjusted operating income and earnings per share to add back non-cash purchase accounting intangible amortization and recast the 2022 amounts to reflect the change on a comparative basis. Adjusted net income was $202 million, or $0.98 per share, which excludes the impacts of special items of purchase accounting intangible amortization, restructuring, realignment, and special charges.

Second-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 19.1 percent, reflecting a year-over-year increase of 250 basis points. Excluding Evoqua results, adjusted EBITDA margin was 18.6 percent, up 200 basis points over the prior year period. Strong price realization more than offset inflation and, coupled with productivity savings and higher volume, drove the margin expansion, exceeding the impact of strategic investments.

Following the close of the Evoqua acquisition, Xylem is now reporting in four segments: Measurement & Control Solutions; Water Infrastructure, now including legacy-Evoqua’s Applied Product Technologies segment; Applied Water; and Integrated Solutions & Services as a new stand-alone segment (with the same perimeter as the legacy-Evoqua segment of the same name) to provide continued transparency on the segment’s performance.

Outlook

Xylem is updating its full-year 2023 guidance to reflect strong organic performance, the combination with Evoqua and the adjustment of purchase accounting intangible amortization.

Xylem now expects full-year 2023 revenue of approximately $7.2 billion, up approximately 30 percent on a reported basis and up 9 to 10 percent on an organic basis. This represents an increase from the Company’s previous full-year guidance of 8 to 9 percent on an organic and reported basis.

Full-year 2023 adjusted EBITDA margin is expected to be approximately 18 percent, lifted from the previous range of 17.5 to 18.0 percent. This results in adjusted earnings per share of $3.50 to $3.70, raised from the previous range of $3.15 to $3.35. This increase of $0.35 at the mid-point includes an organic increase of $0.15 driven by continuing strong demand, and commercial and operational momentum.

Further 2023 planning assumptions are included in Xylem’s second-quarter 2023 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Second Quarter Segment Results

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.

• Second-quarter 2023 revenue was $415 million, up 20 percent on a reported basis and 21 percent organically, versus the prior year period. Growth was robust across the portfolio and led primarily by strong demand and backlog execution in smart metering.

• Second-quarter reported operating income for the segment was $26 million, compared to a $5 million loss in the same period last year. Adjusted operating income, which excludes $3 million of restructuring and realignment costs and $17 million of purchase accounting intangible amortization, was $46 million, a 188 percent increase versus the prior year period, recast to add back $17 million of non-cash purchase accounting amortization. The segment reported operating margin was 6.3 percent, up 770 basis points versus the prior year period. Adjusted operating margin of 11.1 percent increased 650 basis points over the prior year period. Adjusted EBITDA margin was 15.7 percent, up 590 basis points from the prior year period. Higher volume, strong price realization, and productivity savings exceeded the impact of inflation and unfavorable mix.

Water Infrastructure

Xylem’s Water Infrastructure segment, now including legacy-Evoqua’s Applied Product Technologies segment, consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

• Second-quarter 2023 revenue was $704 million, a 20 percent increase on a reported basis and 13 percent organically, compared with second-quarter 2022. This strong growth was driven by price realization and robust utilities and industrial demand, particularly in the U.S. and Western Europe.

• Second-quarter reported operating income for the segment was $106 million, a 2 percent decrease versus the same period last year. Adjusted operating income, which excludes $12 million of special charges, $3 million of restructuring and realignment costs, and $8 million of purchase accounting intangible amortization, was $129 million. This represents a 15 percent increase versus the prior year period, which was recast to add back $1 million of non-cash purchase accounting amortization. Reported operating margin for the segment was 15.1 percent, down 320 basis points versus the prior year period, and adjusted operating margin was 18.3 percent, down 70 basis points versus the prior year period. Adjusted EBITDA margin was 21.4 percent, flat from the prior year. Excluding Evoqua, adjusted EBITDA margin was 21.6 percent, up 20 basis points on the prior year. Favorable price realization and volume improvements were offset by investments, foreign exchange effects, and unfavorable mix.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

• Second-quarter 2023 revenue was $478 million, an 11 percent increase on a reported basis and 12 percent organically, year-over-year. Growth was driven by strong price realization and demand across both industrial and building solutions end-markets, particularly in the U.S. and Emerging Markets.

• Second-quarter reported operating income for the segment was $84 million, a 38 percent increase versus the same period last year. Adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $86 million, a 37 percent increase versus the same period last year. The segment reported operating margin was 17.6 percent, up 340 basis points versus the prior year period. Adjusted operating margin increased 330 basis points over the prior year period to 18.0 percent. Adjusted EBITDA margin was 19.0 percent, up 290 basis points from the prior year. Margin expansion was driven by strong price realization, more than offsetting inflation, coupled with productivity savings.

Integrated Solutions & Services

Xylem’s new Integrated Solutions & Services segment, as of May 24, consists of its portfolio of businesses providing water treatment systems and solutions, with an extensive service branch network and fleet of mobile assets.

• Second-quarter 2023 included revenue of $125 million.

• Second-quarter reported operating loss for the segment was $7 million. Adjusted operating income was $18 million, which excludes $7 million of special charges, $7 million of restructuring and realignment costs, and $11 million of purchase accounting intangible amortization. The segment reported operating margin was (5.6) percent. Adjusted operating margin was 14.4 percent. Adjusted EBITDA margin was 24.0 percent reflecting strong margin performance driven by effective price-cost discipline and productivity.

Supplemental information on Xylem’s second quarter 2023 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving the world’s critical water, wastewater, and water-related challenges through technology, innovation, and expertise. Our more than 22,000 diverse employees delivered combined pro forma revenue of $7.3 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in more than 150 countries become water-secure. Join us in the effort at www.xylem.com and Let’s Solve Water.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine, and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; the global impact of the COVID-19 pandemic on the macroeconomy and our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; failure to successfully execute large projects, including with respect to meeting performance guarantees and customers’ safety requirements; our ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; safe and compliant handling of wastewater and hazardous materials; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on our business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness, and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, our products, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; risks related to our recently completed acquisition of Evoqua, including related to our ability to retain and hire key personnel, the realization of expected benefits and synergies, the need to incur additional or unexpected costs, charges or expenses associated with the integration of the combined companies, delays or challenges with the integration, potential adverse reactions or changes to relationships with customers, suppliers, distributors and other business partners, competitive responses to the acquisition, actual or potential litigation and associated costs and expenses, and impacts to our share price and dilution of shareholders’ ownership; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
	Three Months						Six Months
For the period ended June 30,	2023			2022			2023			2022
Revenue	$	1,722		$	1,364		$	3,170		$	2,636
Cost of revenue		1,071			844			1,973			1,649
Gross profit		651			520			1,197			987
Selling, general and administrative expenses		446			314			800			618
Research and development expenses		58			53			111			105
Restructuring and asset impairment charges		28			7			36			7
Operating income		119			146			250			257
Interest expense		12			12			21			25
Other non-operating income, net		7			2			11			1
Gain from sale of business		—			—			—			1
Income before taxes		114			136			240			234
Income tax expense		22			24			49			40
Net income	$	92		$	112		$	191		$	194
Earnings per share:
Basic	$	0.45		$	0.62		$	0.99		$	1.07
Diluted	$	0.45		$	0.62		$	0.98		$	1.07
Weighted average number of shares:
Basic		205.5			180.2			193.0			180.2
Diluted		206.7			180.6			194.0			180.8

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)
	June 30, 2023				December 31, 2022
ASSETS
Current assets:
Cash and cash equivalents	$	708			$	944
Receivables, less allowances for discounts, returns and credit losses of $45 and $50 in 2023 and 2022, respectively		1,659				1,096
Inventories		1,143				799
Prepaid and other current assets		225				173
Total current assets		3,735				3,012
Property, plant and equipment, net		1,144				630
Goodwill		7,108				2,719
Other intangible assets, net		3,188				930
Other non-current assets		922				661
Total assets	$	16,097			$	7,952
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	968			$	723
Accrued and other current liabilities		1,074				867
Short-term borrowings and current maturities of long-term debt		240				—
Total current liabilities		2,282				1,590
Long-term debt		2,267				1,880
Accrued post-retirement benefits		293				286
Deferred income tax liabilities		738				222
Other non-current accrued liabilities		607				471
Total liabilities		6,187				4,449
Stockholders’ equity:
Common stock – par value $0.01 per share:
Authorized 750.0 shares, issued 256.6 shares and 196.0 shares in 2023 and 2022, respectively		3				2
Capital in excess of par value		8,495				2,134
Retained earnings		2,344				2,292
Treasury stock – at cost 15.9 shares and 15.8 shares in 2023 and 2022, respectively		(717	)			(708	)
Accumulated other comprehensive loss		(226	)			(226	)
Total stockholders’ equity		9,899				3,494
Non-controlling interests		11				9
Total equity		9,910				3,503
Total liabilities and stockholders’ equity	$	16,097			$	7,952

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the six months ended June 30,	2023				2022
Operating Activities
Net income		191				194
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		69				56
Amortization		83				62
Share-based compensation		27				18
Restructuring and asset impairment charges		36				7
Gain from sale of business		—				(1	)
Other, net		(5	)			6
Payments for restructuring		(9	)			(5	)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables		(122	)			(119	)
Changes in inventories		(57	)			(189	)
Changes in accounts payable		36				40
Changes in accrued and deferred taxes		(86	)			(2	)
Other, net		(154	)			(35	)
Net Cash – Operating activities		9				32
Investing Activities
Capital expenditures		(103	)			(95	)
Acquisitions of businesses, net of cash acquired		(476	)			—
Proceeds from sale of business		91				1
Proceeds from the sale of property, plant and equipment		—				3
Cash received from investments		—				4
Cash paid for investments		—				(7	)
Cash paid for equity investments		(56	)			(1	)
Cash received from interest rate swaps		38				—
Cash received from cross-currency swaps		14				11
Other, net		3				—
Net Cash – Investing activities		(489	)			(84	)
Financing Activities
Short-term debt issued, net		74				—
Long-term debt issued, net		275				—
Long-term debt repaid		(1	)			—
Repurchase of common stock		(9	)			(52	)
Proceeds from exercise of employee stock options		40				3
Dividends paid		(139	)			(110	)
Other, net		(5	)			1
Net Cash – Financing activities		235				(158	)
Effect of exchange rate changes on cash		9				(26	)
Net change in cash and cash equivalents		(236	)			(236	)
Cash and cash equivalents at beginning of year		944				1,349
Cash and cash equivalents at end of period	$	708			$	1,113
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	30			$	40
Income taxes (net of refunds received)	$	135			$	42

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses and other non-recurring, significant non-cash impacts, such as non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

"Adjusted Free Cash Flow" defined as free cash flow adjusted for significant cash items for which the corresponding income statement impact does not occur within the same fiscal year.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders ($ Millions)
	(As Reported - GAAP)										(As Adjusted - Organic)											Constant Currency
			(A)		(B)						(C)			(D)		(E) = B+C+D			(F) = E/A			(G) = (E - C) / A
					Change			% Change			Acquisitions / Divestitures					Change			% Change
	Orders		Orders		2023 v. 2022			2023 v. 2022						FX Impact		Adj. 2023 v. 2022			Adj. 2023 v. 2022
	2023		2022
Six Months Ended June 30
Xylem Inc.	3,426		3,399		27			1	%		(222	)		76		(119	)		(4	%)		3	%
Water Infrastructure	1,390		1,391		(1	)		(0	%)		(59	)		42		(18	)		(1	%)		3	%
Applied Water	928		985		(57	)		(6	%)		-			24		(33	)		(3	%)		(3	%)
Measurement & Control Solutions	945		1,023		(78	)		(8	%)		-			10		(68	)		(7	%)		(7	%)
Integrated Solutions and Services	163				163			n/a			(163	)		-		-			n/a			n/a
Quarter Ended June 30
Xylem Inc.	1,856		1,684		172			10	%		(222	)		23		(27	)		(2	%)		12	%
Water Infrastructure	751		731		20			3	%		(59	)		13		(26	)		(4	%)		5	%
Applied Water	445		480		(35	)		(7	%)		-			6		(29	)		(6	%)		(6	%)
Measurement & Control Solutions	497		473		24			5	%		-			4		28			6	%		6	%
Integrated Solutions and Services	163				163			n/a			(163	)		-		-			n/a			n/a
Quarter Ended March 31
Xylem Inc.	1,570		1,715		(145	)		(8	%)		-			53		(92	)		(5	%)		(5	%)
Water Infrastructure	639		660		(21	)		(3	%)		-			29		8			1	%		1	%
Applied Water	483		505		(22	)		(4	%)		-			18		(4	)		(1	%)		(1	%)
Measurement & Control Solutions	448		550		(102	)		(19	%)		-			6		(96	)		(17	%)		(17	%)

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue ($ Millions)
	(As Reported - GAAP)									(As Adjusted - Organic)										Constant Currency
			(A)		(B)					(C)			(D)		(E) = B+C+D		(F) = E/A			(G) = (E - C) / A
					Change		% Change			Acquisitions / Divestitures					Change		% Change
	Revenue		Revenue		2023 v. 2022		2023 v. 2022						FX Impact		Adj. 2023 v. 2022		Adj. 2023 v. 2022
	2023		2022
Six Months Ended June 30
Xylem Inc.	3,170		2,636		534		20	%		(178	)		64		420		16	%		23	%
Water Infrastructure	1,293		1,122		171		15	%		(53	)		37		155		14	%		19	%
Applied Water	931		854		77		9	%		-			17		94		11	%		11	%
Measurement & Control Solutions	821		660		161		24	%		-			10		171		26	%		26	%
Integrated Solutions and Services	125				125		n/a			(125	)		-		-		n/a			n/a
Quarter Ended June 30
Xylem Inc.	1,722		1,364		358		26	%		(178	)		19		199		15	%		28	%
Water Infrastructure	704		589		115		20	%		(53	)		12		74		13	%		22	%
Applied Water	478		429		49		11	%		-			4		53		12	%		12	%
Measurement & Control Solutions	415		346		69		20	%		-			3		72		21	%		21	%
Integrated Solutions and Services	125				125		n/a			(125	)		-		-		n/a			n/a
Quarter Ended March 31
Xylem Inc.	1,448		1,272		176		14	%		-			45		221		17	%		17	%
Water Infrastructure	589		533		56		11	%		-			25		81		15	%		15	%
Applied Water	453		425		28		7	%		-			13		41		10	%		10	%
Measurement & Control Solutions	406		314		92		29	%		-			7		99		32	%		32	%

Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income ($ Millions)
	Q1					Q2					YTD
	2023		2022 (1)			2023		2022 (1)			2023		2022 (1)
Total Revenue
• Total Xylem	1,448		1,272			1,722		1,364			3,170		2,636
• Water Infrastructure	589		533			704		589			1,293		1,122
• Applied Water	453		425			478		429			931		854
• Measurement & Control Solutions	406		314			415		346			821		660
• Integrated Solutions and Services	-		-			125		-			125		-
Operating Income (Loss)
• Total Xylem	131		111			119		146			250		257
• Water Infrastructure	70		74			106		108			176		182
• Applied Water	83		59			84		61			167		120
• Measurement & Control Solutions	20		(10	)		26		(5	)		46		(15	)
• Integrated Solutions and Services	-		-			(7	)	-			(7	)	-
• Total Segments	173		123			209		164			382		287
Operating Margin
• Total Xylem	9.0	%	8.7	%		6.9	%	10.7	%		7.9	%	9.7	%
• Water Infrastructure	11.9	%	13.9	%		15.1	%	18.3	%		13.6	%	16.2	%
• Applied Water	18.3	%	13.9	%		17.6	%	14.2	%		17.9	%	14.1	%
• Measurement & Control Solutions	4.9	%	(3.2	%)		6.3	%	(1.4	%)		5.6	%	(2.3	%)
• Integrated Solutions and Services	N/A		N/A			(5.6	%)	N/A			(5.6	%)	N/A
• Total Segments	11.9	%	9.7	%		12.1	%	12.0	%		12.1	%	10.9	%
Special Charges
• Total Xylem	25		1			67		1			92		2
• Water Infrastructure			-			12		-			12		-
• Applied Water			-			-		-			-		-
• Measurement & Control Solutions	2		-			-		1			2		1
• Integrated Solutions and Services	-		-			7		-			7		-
• Total Segments	2		-			19		1			21		1
Restructuring & Realignment Costs
• Total Xylem	11		4			37		8			48		12
• Water Infrastructure	3		1			3		3			6		4
• Applied Water	3		1			2		2			5		3
• Measurement & Control Solutions	5		2			3		3			8		5
• Integrated Solutions and Services	-		-			7		-			7		-
• Total Segments	11		4			15		8			26		12
Purchase Accounting Intangible Amortization Adjustment
• Total Xylem	18		18			36		18			54		36
• Water Infrastructure	1		1			8		1			9		2
• Applied Water						-		-			-		0
• Measurement & Control Solutions	17		17			17		17			34		34
• Integrated Solutions and Services	-		-			11		-			11		-
• Total Segments	18		18			36		18			54		36
Adjusted Operating Income (Loss)
• Total Xylem	185		134			259		173			444		307
• Water Infrastructure	74		76			129		112			203		188
• Applied Water	86		60			86		63			172		123
• Measurement & Control Solutions	44		9			46		16			90		25
• Integrated Solutions and Services	-		-			18		-			18		-
• Total Segments	204		145			279		191			483		336
Adjusted Operating Margin
• Total Xylem	12.8	%	10.5	%		15.0	%	12.7	%		14.0	%	11.6	%
• Water Infrastructure	12.6	%	14.3	%		18.3	%	19.0	%		15.7	%	16.8	%
• Applied Water	19.0	%	14.1	%		18.0	%	14.7	%		18.5	%	14.4	%
• Measurement & Control Solutions	10.8	%	2.9	%		11.1	%	4.6	%		11.0	%	3.8	%
• Integrated Solutions and Services	N/A		N/A			14.4	%	N/A			14.4	%	N/A
• Total Segments	14.1	%	11.4	%		16.2	%	14.0	%		15.2	%	12.7	%
(1) 2022 amounts have been recast to adjust for historical purchase accounting intangible amortization.

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
		Q2 2023												Q2 2022 (1)
		As Reported				Adjustments				Adjusted				As Reported				Adjustments				Adjusted
	Total Revenue		1,722				-				1,722				1,364				-				1,364
	Operating Income		119				140		a		259				146				27		a		173
	Operating Margin		6.9	%							15.0	%			10.7	%							9.1	%
	Interest Expense		(12	)			-				(12	)			(12	)			-				(12	)
	Other Non-Operating Income (Expense)		7				-				7				2				2		b		4
	Income before Taxes		114				140				254				136				29				165
	Provision for Income Taxes		(22	)			(30	)	c		(52	)			(24	)			(7	)	c		(31	)
	Net Income		92				110				202				112				22				134
	Diluted Shares		206.7								206.7				180.6								180.6
	Diluted EPS	$	0.45			$	0.53			$	0.98			$	0.62			$	0.12			$	0.74
	Year-over-year currency translation impact on current year diluted EPS	$	0.00			$	0.00			$	0.00
	Diluted EPS at Constant Currency	$	0.45			$	0.53			$	0.98
		Q2 YTD 2023												Q2 YTD 2022 (1)
		As Reported				Adjustments				Adjusted				As Reported				Adjustments				Adjusted
	Total Revenue		3,170								3,170				2,636				-				2,636
	Operating Income		250				194		a		444				257				50		a		307
	Operating Margin		7.9	%							14.0	%			9.7	%							9.1	%
	Interest Expense		(21	)			-				(21	)			(25	)			-				(25	)
	Other Non-Operating Income (Expense)		11				-				11				1				3		b		4
	Gain/(Loss) From Sale of Business		-				-				-				1				(1	)			-
	Income before Taxes		240				194				434				234				52				286
	Provision for Income Taxes		(49	)			(39	)	c		(88	)			(40	)			(15	)	c		(55	)
	Net Income Attributable to Xylem		191				155				346				194				37				231
	Diluted Shares		194.0								194.0				180.8								180.8
	Diluted EPS	$	0.98			$	0.80			$	1.78			$	1.07			$	0.21			$	1.28
	Year-over-year currency translation impact on current year diluted EPS	($	0.04	)		$	0.00			($	0.04	)
	Diluted EPS at Constant Currency	$	1.02			$	0.80			$	1.82
	(1) 2022 amounts have been recast to adjust for historical purchase accounting intangible amortization.
a	Quarter-to-date:
	Restructuring & realignment costs: $37 million in 2023 and $8 million in 2022
	Special charges: 2023 - $61 million of acquisition & integration related costs and $6 million of other special charges; 2022 - $1 million of intangible asset impairment charges
	Purchase accounting intangible amortization: $36 million in 2023 and $18 million in 2022
	Year-to-date:
	Restructuring & realignment costs: $48 million in 2023 and $12 million in 2022
	Special charges: 2023 - $84 million of acquisition & integration related costs, $6 million of other special charges and $2 million of intangible asset impairment charges; 2022 - $1 million of intangible asset impairment charges and $1 million of other special charges
	Purchase accounting intangible amortization: $54 million in 2023 and $36 million in 2022
b	Quarter-to-date and Year-to-date: 2022 - Special non-operating charges consist of charges related to the UK pension plan exited as part of a buy-out of $2 million and $3 million, respectively
c	Quarter-to-date: 2023 - Net tax impact on pre-tax adjustments (note a and b) of $30 million; 2022 - Net tax impact on pre-tax adjustments (note a and b) of $6 million and other tax special items of $1 million
	Year-to-date: 2023 - Net tax impact on pre-tax adjustments (note a and b) of $39 million; 2022 - Net tax impact on pre-tax adjustments (note a and b) of $13 million and other tax special items of $2 million

Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow ($ Millions)
		Q1								Q2								Year-to-Date
		2023				2022				2023				2022				2023				2022
Net Cash - Operating Activities		($	19	)		($	81	)		$	28			$	113			$	9			$	32
Capital Expenditures - PP&E			(33	)			(31	)			(70	)			(30	)			(103	)			(61	)
Capital Expenditures - Software			(16	)			(18	)			16				(16	)			0				(34	)
Capital Expenditures			(49	)			(49	)			(54	)			(46	)			(103	)			(95	)
Cash paid in excess of tax provision for R&D law change adoption			33				-				-				-				33				-
Free Cash Flow		($	35	)		($	130	)		($	26	)		$	67			($	61	)		($	63	)
Cash paid by Xylem for Evoqua's pre-close transaction costs			-				-				70				-				70				-
Cash paid for Idrica distribution agreement			-				-				60				-				60				-
Adjusted Free Cash Flow		($	35	)		($	130	)		$	104			$	67			$	69			($	63	)
Net Income		$	99			$	82			$	92			$	112			$	191			$	194
Gain/(Loss) from sale of business			-				1				-				-				-				1
Restructuring Charges - non-cash stock acceleration			-				-				(14	)			-				(14	)			-
Special Charges - Inventory step-up			-				-				(15	)			-				(15	)			-
Special Charges - non-cash impairment			(2	)			-				-				(1	)			(2	)			(1	)
Net Income, excluding gain on sale of businesses and non-cash restructuring and special charges		$	101			$	81			$	121			$	113			$	222			$	194
Operating Cash Flow Conversion			-19	%			-99	%			30	%			101	%			5	%			16	%
Free Cash Flow Conversion			-35	%			-160	%			86	%			59	%			31	%			-32	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2023
		Q1			Q2			Q3			Q4			Total
Net Income		99			92									191
Net Income margin		6.8	%		5.3	%								6.0	%
Depreciation		28			41									69
Amortization		32			51									83
Interest Expense (Income), net		2			5									7
Income Tax Expense		27			22									49
EBITDA		188			211									399
Share-based Compensation		12			15									27
Restructuring & Realignment		11			36									47
Special Charges		25			67									92
Adjusted EBITDA		236			329			-			-			565
Revenue		1,448			1,722									3,170
Adjusted EBITDA Margin		16.3	%		19.1	%								17.8	%
2022
		Q1			Q2			Q3			Q4			Total
Net Income		82			112			12			149			355
Net Income margin		6.4	%		8.2	%		0.9	%		9.9	%		6.4	%
Depreciation		28			28			27			28			111
Amortization		30			32			31			32			125
Interest Expense (Income), net		11			10			7			6			34
Income Tax Expense		16			24			5			40			85
EBITDA		167			206			82			255			710
Share-based Compensation		9			9			10			9			37
Restructuring & Realignment		4			8			6			16			34
U.K. Pension Settlement		-			-			140			-			140
Special Charges		2			3			14			1			20
Loss/(Gain) from sale of business		(1	)		-			-			-			(1	)
Adjusted EBITDA		181			226			252			281			940
Revenue		1,272			1,364			1,380			1,506			5,522
Adjusted EBITDA Margin		14.2	%		16.6	%		18.3	%		18.7	%		17.0	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Water Infrastructure
2023
		Q1			Q2			Q3			Q4			Total
Operating Income		70			106									176
Depreciation		12			14									26
Amortization		2			10									12
Other non-operating expense, excluding interest income		-			1									1
EBITDA		84			131			-			-			215
Share-based Compensation		2			5									7
Restructuring & Realignment		3			3									6
Special Charges		-			12									12
Adjusted EBITDA		89			151			-			-			240
Revenue		589			704									1,293
Adjusted EBITDA Margin		15.1	%		21.4	%								18.6	%
2022
		Q1			Q2			Q3			Q4			Total
Operating Income		74			108			104			132			418
Depreciation		11			11			11			11			44
Amortization		2			3			1			3			9
Other non-operating expense, excluding interest income		(4	)		1			-			(1	)		(4	)
EBITDA		83			123			116			145			467
Share-based Compensation		1			-			-			1			2
Restructuring & Realignment		1			3			3			4			11
Adjusted EBITDA		85			126			119			150			480
Revenue		533			589			574			668			2,364
Adjusted EBITDA Margin		15.9	%		21.4	%		20.7	%		22.5	%		20.3	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Applied Water
2023
		Q1			Q2			Q3			Q4			Total
Operating Income		83			84									167
Depreciation		5			4									9
Amortization		-			1									1
Other non-operating expense, excluding interest income		(1	)		-									(1	)
EBITDA		87			89			-			-			176
Share-based Compensation		1			-									1
Restructuring & Realignment		3			2									5
Special Charges		-			-									-
Adjusted EBITDA		91			91			-			-			182
Revenue		453			478									931
Adjusted EBITDA Margin		20.1	%		19.0	%								19.5	%
2022
		Q1			Q2			Q3			Q4			Total
Operating Income		59			61			77			61			258
Depreciation		5			4			4			4			17
Amortization		-			1			-			1			2
Other non-operating expense, excluding interest income		(1	)		-			(1	)		-			(2	)
EBITDA		63			66			80			66			275
Share-based Compensation		1			1			2			-			4
Restructuring & Realignment		1			2			1			9			13
Adjusted EBITDA		65			69			83			75			292
Revenue		425			429			458			455			1,767
Adjusted EBITDA Margin		15.3	%		16.1	%		18.1	%		16.5	%		16.5	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Measurement & Control Solutions
2023
		Q1			Q2			Q3			Q4			Total
Operating Income		20			26									46
Depreciation		7			9									16
Amortization		27			26									53
EBITDA		54			61			-			-			115
Share-based Compensation		2			2									4
Restructuring & Realignment		5			2									7
Special Charges		2			-									2
Adjusted EBITDA		63			65			-			-			128
Revenue		406			415									821
Adjusted EBITDA Margin		15.5	%		15.7	%								15.6	%
2022
		Q1			Q2			Q3			Q4			Total
Operating Income		(10	)		(5	)		(2	)		19			2
(Loss)/Gain from sale of business		1			-			-			-			1
Depreciation		9			8			8			8			33
Amortization		25			26			27			26			104
Other non-operating expense, excluding interest income		-			(1	)		(1	)		-			(2	)
EBITDA		25			28			32			53			138
Share-based Compensation		1			2			2			1			6
Restructuring & Realignment		2			3			2			3			10
Special Charges		-			1			12			1			14
Loss/(Gain) from sale of business		(1	)		-			-			-			(1	)
Adjusted EBITDA		27			34			48			58			167
Revenue		314			346			348			383			1,391
Adjusted EBITDA Margin		8.6	%		9.8	%		13.8	%		15.1	%		12.0	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Integrated Solutions and Services
2023
		Q1		Q2			Q3		Q4		Total
Operating Income		-		(7	)						(7	)
Depreciation		-		8							8
Amortization		-		12							12
EBITDA		-		13			-		-		13
Share-based Compensation		-		3							3
Restructuring & Realignment		-		7							7
Special Charges		-		7							7
Adjusted EBITDA		-		30			-		-		30
Revenue		-		125							125
Adjusted EBITDA Margin				24.0	%						24.0	%